Literature DB >> 32250183

Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome.

Fardowsa LA Yusuf1, José Ma Wijnands2, Elaine Kingwell2, Feng Zhu2, Charity Evans3, John D Fisk4, Yinshan Zhao5, Jason M Sutherland6, David M Patrick7, Ruth Ann Marrie8, Helen Tremlett2.   

Abstract

BACKGROUND: There is increasing evidence of prodromal multiple sclerosis (MS).
OBJECTIVE: The aim of this study was to determine whether fatigue, sleep disorders, anaemia or pain form part of the MS prodrome.
METHODS: This population-based matched cohort study used linked administrative and clinical databases in British Columbia, Canada. The odds of fatigue, sleep disorders, anaemia and pain in the 5 years preceding the MS cases' first demyelinating claim or MS symptom onset were compared with general population controls. The frequencies of physician visits for these conditions were also compared. Modifying effects of age and sex were evaluated.
RESULTS: MS cases/controls were assessed before the first demyelinating event (6863/31,865) or MS symptom onset (966/4534). Fatigue (adj.OR: 3.37; 95% CI: 2.76-4.10), sleep disorders (adj.OR: 2.61; 95% CI: 2.34-2.91), anaemia (adj.OR: 1.53; 95% CI: 1.32-1.78) and pain (adj.OR: 2.15; 95% CI: 2.03-2.27) during the 5 years preceding the first demyelinating event were more frequent among cases, and physician visits increased for cases relative to controls. The association between MS and anaemia was greater for men; that between MS and pain increased with age. Pre-MS symptom onset, sleep disorders (adj.OR: 1.72; 95% CI: 1.12-2.56) and pain (adj.OR: 1.53; 95% CI: 1.32-1.76) were more prevalent among cases.
CONCLUSION: Fatigue, sleep disorders, anaemia and pain were elevated before the recognition of MS. The relative anaemia burden was higher in men and pain more evident among older adults.

Entities:  

Keywords:  Multiple sclerosis; health care utilization; population-based data; prodrome

Year:  2020        PMID: 32250183     DOI: 10.1177/1352458520908163

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  5 in total

1.  The Multiple Sclerosis Prodrome: Evidence to Action.

Authors:  Helen Tremlett; Kassandra L Munger; Naila Makhani
Journal:  Front Neurol       Date:  2022-01-31       Impact factor: 4.086

2.  Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis.

Authors:  Daniel Jons; Henrik Zetterberg; Martin Biström; Lucia Alonso-Magdalena; Martin Gunnarsson; Magnus Vrethem; Kaj Blennow; Staffan Nilsson; Peter Sundström; Oluf Andersen
Journal:  Ann Clin Transl Neurol       Date:  2022-05-03       Impact factor: 5.430

3.  Involvement of TLR2-TLR4, NLRP3, and IL-17 in pain induced by a novel Sprague-Dawley rat model of experimental autoimmune encephalomyelitis.

Authors:  Andrew J Kwilasz; Madison A Clements; Tracey A Larson; Kevin M Harris; Scott T Litwiler; Brodie J Woodall; Laurel S Todd; Anouk E W Schrama; Eric H Mitten; Steven F Maier; Anne-Marie Van Dam; Kenner C Rice; Linda R Watkins
Journal:  Front Pain Res (Lausanne)       Date:  2022-09-13

Review 4.  The multiple sclerosis prodrome.

Authors:  Naila Makhani; Helen Tremlett
Journal:  Nat Rev Neurol       Date:  2021-06-21       Impact factor: 42.937

Review 5.  Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Joseph A Lopez; Martina Denkova; Sudarshini Ramanathan; Russell C Dale; Fabienne Brilot
Journal:  Clin Transl Immunology       Date:  2021-07-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.